-transparent.png){kind=logo}
The in vitro activity of 13 beta-lactam antibiotics against 1474 recent clinical isolates was evaluated in a multilaboratory study. The most active antibiotic tested in this study was imipenem (98.5% of the strains were susceptible), followed by ticarcillin-clavulanate (91.4%), cefoperazone (90.0%), ceftazidime (87.9%), cefotaxime (87.7%), ceftriaxone (87.0%), ceftizoxime (86.3%), cefotetan (78.5%), ampicillin-sulbactam (77.9%), cefoxitin (73.5%), cefuroxime (70.9%), cefonicid (64.5%), and cefazolin (57.9%).
Related Publications
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
February 1988,
Diagnostic microbiology and infectious disease,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
November 1981,
Antimicrobial agents and chemotherapy,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
February 1980,
Antimicrobial agents and chemotherapy,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
June 1987,
Arzneimittel-Forschung,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
January 1984,
Scandinavian journal of infectious diseases. Supplementum,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
March 1999,
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
October 1982,
Antimicrobial agents and chemotherapy,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
January 1979,
Chemotherapy,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
January 1990,
Reviews of infectious diseases,
P R Murray, and
R N Jones, and
S D Allen, and
M E Erwin, and
P C Fuchs, and
E H Gerlach
February 1978,
Antimicrobial agents and chemotherapy,
